kuano
13 employees on LinkedIn · 3 known investors
Quantum Lens develops a quantum computing and AI platform for drug discovery that simulates molecular behavior at the atomic level to guide the design of novel drug candidates. The platform targets pharmaceutical companies and biotech researchers working on small-molecule drug discovery, particularly for challenging targets like covalent inhibitors, hard-to-drug enzymes, and allosteric binding sites.
Investors · 3
Frequently asked questions
- What does kuano do?
- Quantum Lens develops a quantum computing and AI platform for drug discovery that simulates molecular behavior at the atomic level to guide the design of novel drug candidates. The platform targets pharmaceutical companies and biotech researchers working on small-molecule drug discovery, particularly for challenging targets like covalent inhibitors, hard-to-drug enzymes, and allosteric binding sites.
- Who are kuano's investors?
- kuano's investors include AI Seed, Beresford Ventures, Cambridge Angels group.